Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.45 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.45 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.45 |
| ▸ | ALB | P02768 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | RARB | P10826 | 1/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9176923 | 0.98 | PTGS1 (0.44) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| Bromide SCHEMBL9178738 | 0.98 | PTGS1 (0.44) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL361556 | 0.91 | PTGS1 (0.40) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| Hydrochloric Acid SCHEMBL31093481 | 0.89 | PTGS1 (0.39) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL12748731 | 0.89 | PTGS1 (0.43) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL2913839 | 0.86 | SLC6A4 (0.56) | — | |
| SCHEMBL423511 | 0.86 | TSHR (0.51) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL29973812 | 0.84 | PTGS1 (0.36) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL12770147 | 0.84 | PTGS1 (0.43) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL29408470 | 0.84 | PTGS1 (0.36) | PTGS1PTGS2LMNACYP2C9AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-63275530-A | — | — | None | — | — | JP | disclosed |
| JP-63275532-A | — | — | None | — | — | JP | disclosed |
| JP-63275527-A | — | — | None | — | — | JP | disclosed |
| CN-117098610-A | Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking | 锡克拜控股有限公司 | 2023-11-21 | — | — | CN | disclosed |
| EP-2428501-B1 | DIARYLIODONIUM SALT MIXTURE AND PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF DIARYLIODONIUM COMPOUND | NIPPON CATALYTIC CHEM IND (JP) | 2018-12-12 | — | — | EP | disclosed |
| US-8975203-B2 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2015-03-10 | — | — | US | disclosed |
| EP-2428501-A1 | DIARYL IODONIUM SALT MIXTURE AND PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF DIARYL IODONIUM COMPOUND | Nippon Shokubai Co., Ltd. (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20120053048-A1 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-03-01 | — | — | US | disclosed |
| EP-0470651-B1 | 1,2-Di(4-isobutylphenyl) ethane and its preparation and use as intermediate | NIPPON PETROCHEMICALS CO LTD (JP) | 1995-08-02 | — | — | EP | disclosed |
| EP-0293633-B1 | 1,2-DI(4-ISOBUTYLPHENYL)ETHYLENE AND ITS PREPARATION AND USE AS INTERMEDIATE | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1993-03-10 | — | — | EP | disclosed |
| EP-0290050-A1 | Method for producing alkylstyrene | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1988-11-09 | — | — | EP | disclosed |
| EP-0129956-B1 | PROCESS FOR ARYLATING UNSATURATED COMPOUNDS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1987-07-08 | — | — | EP | disclosed |
| EP-0119067-B1 | PROCESS FOR PREPARING ALDEHYDES | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1986-11-26 | — | — | EP | disclosed |
| US-4607116-A | FROM DIARYLIODONIUM SALT | NIPPON PETROCHEMICALS COMPANY LIMITED (JP) | 1986-08-19 | — | — | US | disclosed |
| EP-0119065-B1 | PROCESS FOR PREPARING DIARYLS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1986-08-13 | — | — | EP | disclosed |
| US-4590281-A | REACTING DIARYLIODONIUM SALT WITH UNSATURATED ALCOHOL | NIPPON PETROCHEMICALS COMPANY (JP) | 1986-05-20 | — | — | US | disclosed |
| US-4554360-A | DIARYLIODONIUM SALT, IODOARENE, COUPLING | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-11-19 | — | — | US | disclosed |
| EP-0129956-A1 | Process for arylating unsaturated compounds | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-01-02 | — | — | EP | disclosed |
| EP-0119065-A1 | Process for preparing diaryls | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-09-19 | — | — | EP | disclosed |
| EP-0119067-A1 | Process for preparing aldehydes | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053048-A1 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | SPIN4, SALL4, DBF4 | PTGS1 3451/4885PTGS2 3250/4885LMNA 4649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.